RT Journal Article
SR Electronic
A1 Mosley, Mary
T1 RDN: Its Current Place in the Treatment of Resistant Hypertension
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 14
IS 16
SP 16
OP 17
DO 10.1177/155989771416013
UL http://mdc.sagepub.com/content/14/16/16.abstract
AB Renal denervation is a promising strategy to treat true treatment-resistant hypertension. However, careful patient selection is required, by a cardiac team using well-defined criteria. Renal denervation should only be performed in an experienced catheterization laboratory performing at least 14 ablations a year. Promising results have been obtained with new ablation devices.